-
Mashup Score: 0Medable at DIA 2023 - 1 year(s) ago
Join us for our session in the innovation theater or stop by our booth to learn how digital offerings can improve patient experiences, see the latest industry research, and pick up Medable swag.
Source: info.medable.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Ethical review of Decentralized Clinical Trials (DCTs): Tools, resources & best practices - 1 year(s) ago
Barbara Bierer (MRCT Center), Pam Tenaerts (Medable) and Leanne Madre (Medable) will present a framework, recommendations, and tools organized around 3 DCT domains: People, Remote Data Collection, and Data Oversight. Best practices for the ethical review, approval, and conduct of DCTs will be provided.
Source: Constant ContactCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1
Along with some of the best companies in the world, Medable is proud to join CancerX as a founding member. This alliance is co-hosted by the Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Medable at DIA 2023 - 2 year(s) ago
Join us for our session in the innovation theater or stop by our booth to learn how digital offerings can improve patient experiences, see the latest industry research, and pick up Medable swag.
Source: info.medable.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Decentralized Clinical Trials Digital Week - 2 year(s) ago
DAY 1 – June 6, 2023 Closing the Acceptance Gap on Decentralised Clinical Trials 9am EST / 2pm BST / 3pm CEST Looking at the various personas a decentralized trial engages with we will look at the barriers to participation/adoption. We will have a call to action from a sponsor, CRO and regulatory space to help continuing to drive…
Source: ms.informaengage.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1
The recent release (May 2023) of the FDA’s Decentralized Clinical Trial (DCT) Draft Guidance has sparked a wave of excitement and anticipation within the field of clinical trials. This long-awaited guidance represents a significant milestone in the evolution of clinical trial methodologies, signaling clear support for the global shift towards expanded trial models. This guidance reinforces the…
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
Despite years of effort, health data remains fragmented across institutions, sectors, and companies. There is no standardized way to collect or store non-individualized patient data; potentially useful information from personal devices often goes unleveraged. Lacking a clear framework, researchers and regulators are uncertain how to integrate real-world data into their work. With the data siloed,…
Source: Milken InstituteCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0SAP Partner Connect at SAP Sapphire Orlando - 2 year(s) ago
Home | SAP Partner Connect
Source: SAP Partner ConnectCategories: Future of Medicine, Latest HeadlinesTweet-
We're honored to take part in the SAP Sapphire Partner Connect event, and also excited to work with @SAP in the future to solve some of the most pressing challenges in clinical research. Register here to find our more on Monday: https://t.co/z3HOZY5u2L #clinicaltrials #research https://t.co/5e5Gc3uGeC
-
-
Mashup Score: 0Healthy Societies Need Healthy Women; Women’s Health Relies on Equitable Clinical Research - 2 year(s) ago
This Mother’s Day, women across the US and in other parts of the world will be celebrated, but this appreciation is not reflected in scientific research, where women continue to face stark inequities.
Source: DIA Global ForumCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Leverage Novel Options in Oncology Clinical Trial Design to Reduce Burden For Patients and Sites | Medable - 2 year(s) ago
The new FDA Patient Focused Drug Development (PFDD) Guidance Series and the Core Patient-Reported Outcomes Measures (PROMs) in Cancer Clinical Trials Guidance demonstrates the industry’s commitment to optimizing clinical trial design, presenting the opportunity to minimize participant and site burden. Traditionally, oncology trials have been solely site-based, with lengthy, complex, and…
Source: www.medable.comCategories: Future of Medicine, Latest HeadlinesTweet
At #DIA2023 join us to discover how & why leading pharma companies are using online platforms to deliver drug development transformation at scale. Explore the evolving regulatory guidance & latest research validating that DCTs are here to stay. Learn more: https://t.co/6vc0P7xwFo https://t.co/M4TYxhbUal